Ricky Goldwasser
Stock Analyst at Morgan Stanley
(4.07)
# 505
Out of 5,146 analysts
232
Total ratings
61.49%
Success rate
8.55%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Overweight | $65 → $49 | $25.10 | +95.22% | 12 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $411 → $409 | $286.66 | +42.68% | 21 | Jan 23, 2026 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $170 → $185 | $175.46 | +5.44% | 23 | Nov 11, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $28 → $38 | $42.93 | -11.48% | 14 | Oct 14, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $283 → $306 | $287.62 | +6.39% | 17 | Jul 25, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $6.96 | +43.68% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $1.99 | +176.38% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $13.66 | -45.10% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $20.42 | -41.23% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $211.10 | -31.31% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $146.36 | +149.39% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $974.45 | -56.90% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $5.75 | +1,986.96% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $186.83 | +231.85% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $323.05 | +54.77% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $78.01 | +58.95% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $288.82 | +10.10% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $227.13 | -69.18% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $170.64 | +14.28% | 6 | Oct 21, 2020 |
Doximity
Feb 6, 2026
Maintains: Overweight
Price Target: $65 → $49
Current: $25.10
Upside: +95.22%
UnitedHealth Group
Jan 23, 2026
Maintains: Overweight
Price Target: $411 → $409
Current: $286.66
Upside: +42.68%
Charles River Laboratories International
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $170 → $185
Current: $175.46
Upside: +5.44%
Centene
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $28 → $38
Current: $42.93
Upside: -11.48%
Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283 → $306
Current: $287.62
Upside: +6.39%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.96
Upside: +43.68%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $1.99
Upside: +176.38%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $13.66
Upside: -45.10%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $20.42
Upside: -41.23%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $211.10
Upside: -31.31%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $146.36
Upside: +149.39%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $974.45
Upside: -56.90%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $5.75
Upside: +1,986.96%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $186.83
Upside: +231.85%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $323.05
Upside: +54.77%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $78.01
Upside: +58.95%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $288.82
Upside: +10.10%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $227.13
Upside: -69.18%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $170.64
Upside: +14.28%